These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33979562)

  • 41. Economic evaluation of an incentive-based program to increase physical activity and reduce sedentary behaviour in middle-aged adults.
    Maple JL; Ananthapavan J; Ball K; Teychenne M; Moodie M
    BMC Health Serv Res; 2022 Jul; 22(1):932. PubMed ID: 35854379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cost-effectiveness analysis of national smoking cessation services among chronic obstructive pulmonary disease patients in Thailand.
    Prasitwarachot R; Thavorn K; Patikorn C; Wattanasirichaigoon S; Rungruanghiranya S; Thongphiew A; Chaiyakunapruk N
    J Med Econ; 2023; 26(1):1377-1385. PubMed ID: 37818930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial.
    Sinclair L; McFadden M; Tilbrook H; Mitchell A; Keding A; Watson J; Bauld L; Kee F; Torgerson D; Hewitt C; McKell J; Hoddinott P; Harris FM; Uny I; Boyd K; McMeekin N; Ussher M; Tappin DM;
    Trials; 2020 Feb; 21(1):183. PubMed ID: 32059684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nationwide expansion of a financial incentive program on fruit and vegetable purchases among Supplemental Nutrition Assistance Program participants: A cost-effectiveness analysis.
    An R
    Soc Sci Med; 2015 Dec; 147():80-8. PubMed ID: 26547363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-Effectiveness of a Health System-Based Smoking Cessation Program.
    Levy DE; Klinger EV; Linder JA; Fleegler EW; Rigotti NA; Park ER; Haas JS
    Nicotine Tob Res; 2017 Nov; 19(12):1508-1515. PubMed ID: 27639095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Cost-Effectiveness Analysis of Stop Smoking Interventions in Substance-Use Disorder Populations.
    Healey A; Roberts S; Sevdalis N; Goulding L; Wilson S; Shaw K; Jolley C; Robson D
    Nicotine Tob Res; 2019 Apr; 21(5):623-630. PubMed ID: 29733376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study.
    Lee Y; Mozaffarian D; Sy S; Huang Y; Liu J; Wilde PE; Abrahams-Gessel S; Jardim TSV; Gaziano TA; Micha R
    PLoS Med; 2019 Mar; 16(3):e1002761. PubMed ID: 30889188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.
    Cantor SB; Deshmukh AA; Luca NS; Nogueras-González GM; Rajan T; Prokhorov AV
    Addict Behav; 2015 Jun; 45():79-86. PubMed ID: 25644592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Competitions and incentives for smoking cessation.
    Hey K; Perera R
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004307. PubMed ID: 15846705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Competitions and incentives for smoking cessation.
    Cahill K; Perera R
    Cochrane Database Syst Rev; 2008 Jul; (3):CD004307. PubMed ID: 18646105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use and impact of incentives in population-based smoking cessation programs: a review.
    Bains N; Pickett W; Hoey J
    Am J Health Promot; 1998; 12(5):307-20. PubMed ID: 10181140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness, Cost-effectiveness, and Cost-Utility of a Digital Smoking Cessation Intervention for Cancer Survivors: Health Economic Evaluation and Outcomes of a Pragmatic Randomized Controlled Trial.
    Mujcic A; Blankers M; Boon B; Verdonck-de Leeuw IM; Smit F; van Laar M; Engels R
    J Med Internet Res; 2022 Mar; 24(3):e27588. PubMed ID: 35297777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of a smoking cessation program implemented at the time of surgery for lung cancer.
    Slatore CG; Au DH; Hollingworth W
    J Thorac Oncol; 2009 Apr; 4(4):499-504. PubMed ID: 19204575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-Effectiveness of Smoking Cessation Interventions in Patients With Ischemic Stroke and Transient Ischemic Attack.
    Wechsler PM; Liberman AL; Restifo D; Abramson EL; Navi BB; Kamel H; Parikh NS
    Stroke; 2023 Apr; 54(4):992-1000. PubMed ID: 36866670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary care.
    Smith MY; Cromwell J; DePue J; Spring B; Redd W; Unrod M
    Manag Care; 2007 Jul; 16(7):48-55. PubMed ID: 17907712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
    Bolin K; Lindgren B; Willers S
    Chest; 2006 Mar; 129(3):651-60. PubMed ID: 16537864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective.
    Javitz HS; Swan GE; Zbikowski SM; Curry SJ; McAfee TA; Decker DL; Patterson R; Jack LM
    Am J Manag Care; 2004 Mar; 10(3):217-26. PubMed ID: 15032259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment.
    Barnett PG; Jeffers A; Smith MW; Chow BK; McFall M; Saxon AJ
    Nicotine Tob Res; 2016 Mar; 18(3):267-74. PubMed ID: 25943761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Economic evaluation of a hospital-initiated intervention for smokers with chronic disease, in Ontario, Canada.
    Mullen KA; Coyle D; Manuel D; Nguyen HV; Pham B; Pipe AL; Reid RD
    Tob Control; 2015 Sep; 24(5):489-96. PubMed ID: 24935442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review.
    Lee D; Lee YR; Oh IH
    Eur J Health Econ; 2019 Dec; 20(9):1409-1424. PubMed ID: 31452084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.